MOSCOW Aug 29 (Reuters) – Indebted Russian drug store chain Pharmacy Chain 36.6 is selling its stake in drug producing unit Veropharm for 5 billion roubles ($151 million) as part of a business restructuring.
The company said in a statement it had agreed to sell Veropharm to GardenHills, a company of Russian businessman Roman Avdeev.
“Today’s deal will reduce the debt burden,” Artem Bektemirov, the CEO and co-owner of Pharmacy Chain 36.6, said in the statement, adding the company also planned to close unprofitable stores to make its retail business more efficient.